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Abstract
Background: Influenza A viruses are well characterized to antagonize type I IFN induction in infected mammalian cells.
However, limited information is available for avian cells. It was hypothesised that avian influenza viruses (AIV) with
distinct virulence may interact differently with the avian innate immune system. Therefore, the type I IFN responses
induced by highly virulent and low virulent H5N1 AIV and reassortants thereof were analysed in chicken cells.
Results: The highly pathogenic (HP) AIV A/chicken/Yamaguchi/7/04 (H5N1) (Yama) did not induce type I IFN in
infected chicken HD-11 macrophage-like cells. This contrasted with an NS1 mutant Yama virus (Yama-NS1
A144V)a n d
with the attenuated H5N1 AIV A/duck/Hokkaido/Vac-1/04 (Vac) carrying the haemagglutinin (HA) of the Yama virus
(Vac-Yama/HA), that both induced type I IFN in these cells. The substitution of the NS segment from Yama with that
from Vac in the Yama backbone resulted in induction of type I IFN secretion in HD-11 cells. However, vice versa, the
Yama NS segment did not prevent type I IFN induction by the Vac-Yama/HA virus. This was different with the PB1/PB2/
PA segment reassortant Yama and Vac-Yama/HA viruses. Whereas the Yama virus with the Vac PB1/PB2/PA segments
induced type I IFN in HD-11 cells, the Vac-Yama/HA virus with the Yama PB1/PB2/PA segments did not. As reported for
mammalian cells, the expression of H5N1 PB2 inhibited the activation of the IFN-b promoter in chicken DF-1 fibroblast
cells. Importantly, the Yama PB2 was more potent at inhibiting the IFN-b promoter than the Vac PB2.
Conclusions: The present study demonstrates that the NS1 protein and the polymerase complex of the HPAIV Yama
act in concert to antagonize chicken type I IFN secretion in HD-11 cells. PB2 alone can also exert a partial inhibitory
effect on type I IFN induction. In conclusion, the control of type I IFN induction by H5N1 HPAIV represents a complex
phenotype that involves a particular viral gene constellation rather than a single viral protein. Collectively, these findings
contribute to understand the high virulence of HPAIV H5N1 viruses observed in the chicken host.
Keywords: H5N1 avian influenza A virus, chicken HD-11 macrophage-like cell line, type I interferon, nonstructural
protein 1, viral polymerase complex
Background
Type I interferons (IFN) exert key functions in the innate
immune defence against influenza A virus infections by
limiting viral spread and replication [1]. Host cells
express a broad repertoire of pattern recognition recep-
tors (PRRs) to viral danger signals. These include the
membrane-bound Toll-like receptors (TLRs) and the
cytoplasmic RIG-I-like receptors (RLRs) that sense
unique viral structures such as single-stranded, double-
stranded or 5’-triphosphorylated RNA [2]. In influenza A
virus (IAV)-infected cells, the viral NS1 protein is
involved in multiple regulatory functions, including the
control of type I interferon (IFN) induction [3,4].
Although most of the studies focussed on the interaction
of IAV with the type I IFN system in mammalian sys-
tems, several studies demonstrated also the critical role
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(AIV) in chicken. A recent study, for instance, reported
that the highly pathogenic (HP) AIV A/goose/Guang-
dong/1/96 (H5N1) antagonized the induction of type I
IFN in chicken embryo fibroblasts, whereas a recombi-
nant virus carrying a valine instead of the alanine at posi-
tion 149 of NS1 lost this function and became avirulent
[5]. Another report demonstrated enhanced virulence
related to a deletion of 5 amino acids in the NS1 protein
at positions 80 to 84, typically observed in recently
emerged HPAIV H5N1 isolates [6]. This deletion is
located within the region that links the dsRNA binding
domain and the effector domain. A study conducted in
ducks reported that the exchange of the NS segments
between a high and a low virulent H5N1 virus had a
minimal impact on pathogenicity [7]. The authors there-
fore suggested other viral genes or combination of genes
to be related to virulence. Mutations at multiple sites of
PB2 contribute to the virulence and adaptation of H5N1
influenza in mice [8-10]. Only recently, the polymerase
subunit PB2 was found to confer importin-a specificity
and therefore to represent an important determinant of
h o s tr a n g e[ 1 1 , 1 2 ] .T h ev i r a lp o l y m e r a s ec o m p l e xw a s
also found to decrease IFN-b induction in mammalian
cells [13,14]. PB2 protein inhibits the transcription of the
IFN-b mRNA by interacting with the RLR-adaptor CAR-
DIF (also known as MAVS, IPS-1, VISA). Along this line,
it was reported that exchanging the PB1, PB2 and NP
segments alters viral replication of H5N1 reassortant
viruses in chicken and can modulate pathogenicity [15].
Furthermore, the PB2 and NP of H5N1 HPAIV are asso-
ciated with increased pathogenicity in chicken [16].
The HPAIV H5N1 A/chicken/Yamaguchi/7/04 (Yama)
[17,18] induces a peracute disease with 100% mortality
within 36 h in experimentally infected chickens [19,20].
Interestingly, a recombinant virus derived from the low
pathogenic (LP) H5N1 virus A/duck/Hokkaido/Vac-1/04
(Vac) [21] and carrying the Yama HA segment (Vac-
Yama/HA) is also virulent, resulting in 100% mortality in
chicken, but with a delay of 48 h when compared with the
Y a m av i r u s[ 2 0 ] .T h i sl a t t e rs t u d ys h o w st h a tt y p eII F N
levels in lung, plasma and spleen are higher with the Yama
virus than with the less virulent Vac-Yama/HA reassor-
tant. Interestingly, infection with virulent AIV results in
high viral load and severe disease in the presence of high
type I IFN levels in the different organs. However, the
impact of systemic type I IFN on disease pathogenesis dur-
ing H5N1 infection of chicken remains elusive. We
recently reported that chicken DF-1 fibroblasts and HD-
11 macrophage-like cells employ MDA5 to sense AIV
infections [22]. Based on these data, the present study was
designed to identify viral factors controlling type I IFN
induction in these two cell lines. To this end, the highly
virulent H5N1 Yama and Vac-Yama/HA and multiple
reassortants thereof were used to infect chicken HD-11
cells, DF-1 fibroblasts and splenocytes. With this in vitro
study, viral genetic elements controlling type I IFN induc-
tion in H5N1 AIV-infected chicken cells were identified.
Results
HPAIV H5N1 as opposed to low pathogenic (LP) AIV do
not induce type I IFN in embryonated chicken eggs
This study employed multiple H5N1 AIV viruses (see
table 1) generated by reverse genetics. These include the
completely attenuated Vac and the highly virulent H5N1
Yama and A/whooper swan/Mongolia/3/05 viruses. In
addition, the HPAIV field isolate A/turkey/Turkey/1/2005
H5N1 was used. A reassortant Vac-derived virus with the
Yama HA segment (Vac-Yama/HA), and a Yama mutant
carrying an NS1 A144V substitution (Yama-NS1
A144V)
corresponding to that described for A/goose/Guangdong/
1/96 (H5N1) at position 149 [5] were generated. The Vac-
Yama/HA was constructed to obtain a virus capable of
replicating in the absence of trypsin. This was necessary
due to the intolerance of HD-11 cells to trypsin. Addi-
tional segment exchange mutant viruses generated are
listed in Table 1. Interestingly, during amplification of AIV
in chicken eggs, some preparations contained antiviral
activity. Therefore, type I IFN in the allantoic fluid was
quantified systematically for all virus preparations. The
three HPAIV H5N1 strains, including Yama, Mongolia-3/
05, and Turkey/Turkey/05 did not induce any type I IFN
in embryonated chicken eggs 24 h after infection (Figure
1A). These findings contrasted with the LPAIV Vac and
the HPAIV Vac-Yama/HA virus that induced approxi-
mately 50 U/ml type I IFN in the infected eggs. Impor-
tantly, 1 day after infection when the allantoic fluids were
harvested, the virus titres were comparable (Figure 1B). In
order to avoid any carryover of chicken type I IFN with
the virus stocks prepared in eggs, all viruses employed to
infect chicken cells were produced in MDCK cells.
The Yama virus does not induce type I IFN in HD-11 cells
In order to determine whether the observations made in
eggs are also true in cell culture, the capacity of H5N1
viruses to induce type I IFN in chicken macrophage-like
HD-11 cells and DF-1 fibroblast cells was investigated.
As shown in Figure 2A, HD-11 cells produced type I IFN
after infection with Vac-Yama/HA but not with Yama.
This contrasted with DF-1 cells, where no type I IFN
secretion was observed with any of these viruses (data
not shown). However, the two viruses replicated to com-
parable levels in the two cell lines (Figure 2B and 2C).
Relating to its inability to propagate in HD-11 cells, the
trypsin-dependent LP Vac virus did not induce type I
IFN in HD-11 cells nor in DF-1 cells (data not shown).
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Considering that HPAIV spreads to lymphoid tissue
during infection in chicken, and that type I IFN
responses are observed in vivo [19,20], the type I IFN
responses to HPAIV infection were analysed in chicken
splenocytes. Contrasting with HD-11 cells, the Yama
virus induced type I IFN in infected splenocytes (Figure
3). Importantly, 2-bromoethylamine hydrobromide
(BEI)-inactivated virus did also stimulate type I IFN pro-
duction in splenocytes. BEI treatment abolished the
infectivity completely, without affecting the capacity of
the virus to haemagglutinate chicken red blood cells,
indicating that the virion structure had maintained its
integrity as shown earlier [23]. Altogether, these data
indicate that Yama virus replication is not required for
virus recognition and activation of type I IFN in chicken
splenocytes.
NS1 is required to prevent type I IFN induction in Yama-
infected HD-11 cells
Based on the known activity of NS1 as type I IFN antago-
nist [5,22], we assessed whether the viral NS1 protein is
required to control type I IFN secretion in HPAIV-
infected HD-11 cells. As opposed to the parental Yama
strain, the NS1 mutant Yama-NS1
A144V induced high
levels of type I IFN in HD-11 cells (Figure 4A). The
induction was dependent on the virus dose (Figure 4B).
Even at high multiplicity of infection (MOI), the Yama
virus did not induce type I IFN in these cells. Surpris-
ingly, despite the induction of type I IFN, the NS1
mutant virus, replicated to titres higher than 10
6 TCID50/
ml in both, HD-11 and DF-1 cells (Figures 4C and 4D).
These data demonstrate that the H5N1 Yama NS1 pro-
tein is required to prevent type I IFN secretion of
infected HD-11 cells.
The Yama NS segment in the Vac backbone is not
sufficient to prevent type I IFN in HD-11 cells
In order to determine the role of the NS segment in the
different ability of the Yama and Vac-Yama/HA viruses
to control type I IFN induction, we constructed NS
Table 1 H5N1 avian influenza A viruses employed in this study
Name Abbreviation or description Pathogenicity in chicken, Reference
A/chicken/Yamaguchi/7/04 Yama HP, [17]
A/duck/Hokkaido/Vac-1/04 Vac LP, [21]
A/whooper swan/Mongolia/3/05 Mongolia/05 HP, [30]
A/turkey/Turkey/1/2005 Turkey/Turkey/05 HP, [31]
Yama-NS1
A144V Yama with mutant NS1 (A144V) unknown
Yama-Vac/NS Yama with Vac NS unknown
Yama-Vac/PB2/PB1/PA Yama with Vac PB2, PB1, PA unknown
Yama-Vac/PB2/PB1/PA/NS Yama with Vac PB2, PB1, PA and NS unknown
Yama-Vac/PB1 Yama with Vac PB1 unknown
Yama-Vac/PB2 Yama with Vac PB2 unknown
Vac-Yama/HA Vac with Yama HA HP, [20]
Vac-Yama/HA/NS Vac with Yama HA and NS unknown
Vac-Yama/HA/PB2/PB1/PA Vac with Yama HA, PB2, PB1, PA unknown
Vac-Yama/HA/PB2/PB1/PA/NS Vac with Yama HA, PB2, PB1, PA and NS unknown
Vac-Yama/HA/PB1 Vac with Yama HA, PB1 unknown
Vac-Yama/HA/PB2 Vac with Yama HA, PB2 unknown
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Figure 1 Induction of type I IFN in H5N1 virus infected
embryonated chicken eggs. 10-day-old embryonated chicken
eggs were inoculated with the indicated viruses with a dose of 10
3
TCID50/egg in 0.2 ml of PBS per egg. Allantoic fluid was harvested
24 h after infection and analysed for type I IFN bioactivity (A) and
virus titre (B). Control allantoic fluid (CAF) was harvested from eggs
inoculated with PBS. The data represent average values with
standard deviations of 5 infected eggs.
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tion of the Vac NS segment into the Yama virus (Yama-
Vac/NS) disrupted the block of type I IFN induction
(Figure 5A). However, introduction of Yama NS in the
Vac-Yama/HA virus did not mediate block of type I IFN
induction (Figure 5B). These results indicate that either
the Yama NS1 requires additional viral determinants
present only in the Yama genetic context, or that other
viral determinants present only in the Yama virus con-
tribute to type I IFN suppression.
The polymerase complex of Yama is involved in the
prevention of type I IFN induction in HD-11 cells
We next assessed the contribution of the polymerase
complex in the control of type I IFN induction in virus
infected HD-11 cells. Interestingly, the Yama virus with
Vac-derived PB2/PB1/PA induced type I IFN, despite of
the expression of Yama/NS1 (Figure 5A). Vice versa, the
Vac-Yama/HA virus carrying all three Yama polymerase
segments (PB2/PB1/PA) showed significantly reduced
type I IFN induction, in comparison to Vac-Yama/HA
(Figure 5B). Together, these results indicate that the
c o n t r o lo ft y p eII F Ni n d u c t i o nb yt h eY a m av i r u si n
HD-11 cells represents a polygenic trait, involving the
NS1 and the polymerase complex. As depicted in Figure
5C and 5D, all viruses grew to comparable titres, show-
ing that the differences in type I IFN induction were not
due to different levels of virus replication. Similarly, no
differences in the kinetics of cell survival between the
different reassortants were observed (data not shown).
Yama PB2 plays a major role in the prevention of type I
IFN induction in infected HD-11 cells
Next, reassortant Yama viruses carrying either the Vac
PB1 or PB2 segments were analysed. The failure of Yama
with Vac PB2 but not with Vac PB1 to control type I
IFN, indicated a role of the Yama PB2 in type I IFN
antagonistic activity of the virus (Figure 5A). The inhibi-
t o r ye f f e c to ft h eY a m aP B 2o nt h et y p eII F Ni n d u c t i o n
pathway was confirmed with Vac-Yama/HA/PB2, as
compared to Vac-Yama/HA (Figure 5B). Nevertheless,
also Vac-Yama/HA/PB1 induced lower levels of type I
IFN compared to Vac-Yama/HA, which may indicate
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Figure 3 The Yama virus induces type I IFN induction in
chicken splenocytes. Chicken splenocytes were stimulated with
live and BEI-inactivated Yama virus at decreasing MOI. At 18 h after
infection, culture supernatants were assayed for type I IFN
bioactivity. Data are shown as average values of triplicate wells with
standard deviations. The data are representative of two
independent experiments.
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Page 4 of 9redundant functions between PB1 and PB2 in inhibition
of type I IFN induction (Figure 5B). In summary, our
data demonstrate that the type I IFN induction in HD-11
cells is counteracted by the Yama polymerase complex
with a prominent role of the PB2 gene segment.
PB2 from the Yama virus exerts a stronger inhibitory
activity on chicken type I IFN induction than PB2 from
the Vac virus
In mammalian cells, PB2 was also found to inhibit IFN-b
induction besides NS1 [13,14]. Consequently, we
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Figure 5 Analysis of type I IFN responses and viral titres after infection of HD-11 cells with various segment-exchange mutant viruses.
HD-11 cells were infected with the indicated viruses at an MOI of 0.05 TCID50/cell. After 24 h the supernatants were analysed for type I IFN
bioactivity (A and B). In parallel, corresponding virus titres were determined at 8 h and 24 h after infection (C and D). The data represent the
mean values with standard deviations obtained from four independent experiments performed at least in triplicate. The asterisks (*) indicate
statistical significant differences between selected viruses compared to Yama (A) or to Vac-Yama/HA (B) calculated with the students t-test (p <
0.05).
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PB2 expression on the activation of the chicken RIG-I-
like receptor pathway using a transient IFN-b promoter
reporter assay in chicken DF-1 fibroblast cells. For this
purpose, the IFN-b promoter was activated by expression
of the chicken (ch) CARDIF and N-terminal domain of
chMDA5 (N-chMDA5). Expression of the Vac or Yama
PB2 proteins (with or without V5-His tag) decreased the
IFN-b promoter activation triggered by chCARDIF and
N-chMDA5 expression (Figure 6A and 6B). This was not
seen with the M1 and PB1-F2 proteins from any of the
two viruses (data not shown). In comparison to the Vac-
derived PB2, expression of the Yama PB2 resulted in sig-
nificantly stronger inhibition of RLR-specific chicken
IFN-b promoter activation. With the tagged proteins,
comparable levels of proteine x p r e s s i o nw e r ed e m o n -
strated (Figure 6C). Interestingly, the Vac PB2 and Yama
PB2 amino acid sequences differ only by four amino
acids (M64I, I67V, T108A and K339T).
Discussion
The present study revealed that type I IFN production in
infected embryonated chicken eggs and HD-11 cells was
related to the virulence of the virus. In particular, infec-
tion of HD-11 cells with the HP Yama virus did not
result in type I IFN secretion, as opposed to infection
with the less virulent Vac-Yama/HA virus. The viral fac-
tors determining type I IFN production were identified
with mutational analyses, revealing the involvement of
NS1 and the PB2 proteins of the Yama virus in the pre-
vention of type IFN induction.
The fact that the A144V mutation within NS1 of the
Yama virus results in strong induction of type I IFN indi-
cates that NS1 functions as an inhibitor of the Yama
virus-mediated type I IFN induction. A critical role of ala-
nine 144 of H5N1 NS1 in the counteraction of type I IFN
induction was also reported for the corresponding alanine
at position 149 of the A/goose/Guangdong/1/96 H5N1
NS1 protein [5]. These data are in agreement with earlier
results showing that type I IFN induction triggered by
MDA5 in chicken cells can be inhibited by NS1 [22].
Interestingly and in apparent contradiction with the situa-
tion in HD-11 cells, stimulation of chicken splenocytes
with live and with BEI-inactivated Yama virus resulted in
considerable type I IFN secretion. Also in experimentally
infected chicken, the Yama virus induces high systemic
levels of type I IFN [19,20]. This may be explained by the
interaction of AIV with specialized type I IFN producing
cells present in splenocyte preparations and in vivo. These
cells may be analogous to the mammalian plasmacytoid
dendritic cells (pDCs), supported by the observation that
their activation was independent of virus replication and
therefore of NS1 expression, as it is the case for mamma-
lian pDCs.
In order to elaborate on the gene segments that may
be involved in the inhibition of type I IFN induction by
the Yama virus, various reassortants of the Yama and
Vac-Yama/HA viruses were analysed for type I IFN
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Figure 6 Effect of PB2 expression on the chicken RLR-specific IFN-b promoter activation. Chicken DF-1 fibroblast cells were transfected
with a mixture of the chicken IFN-b promoter reporter plasmid, and of expression plasmids for untagged or V5- and His-tagged Vac-PB2 or
Yama-PB2 (150 ng/well in A, 50 ng/well in B) and with expression plasmids for either chCARDIF (50 ng/well) or N-chMDA5 (12.5 ng/well) to
trigger the chRLR signalling pathway. At 18 h after infection, the cell lysates were analysed using the dual luciferase assay. Data are shown as
mean values with standard deviations obtained from six transfections. The asterisks (*) indicate statistical significant differences calculated with
the students t-test (p < 0.05). The selected data are representative of two independent experiments. The expression of the V5-His-tagged Vac-
PB2 and Yama-PB2 proteins in transfected DF-1 cells was analysed by Western blotting using the anti-V5 MAb (C). The b-actin content was
determined with the anti-b-actin MAb.
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ment in the Yama backbone abrogated the capacity of
the virus to prevent type I IFN induction, but not vice
versa, indicated that additional viral determinants were
involved in the control of type I IFN induction. As
expected from previous results with mammalian cells
[13,14], we demonstrate a role of the polymerase com-
plex, in particular of PB2, in the prevention of type I
IFN induction in chicken cells. The effect mediated by
PB2 could be measured in the absence of NS1 or other
viral genes. However, the results suggest that the
enhanced inhibitory activity exhibited by the PB2 pro-
tein of the Yama virus is likely to act in concert with
NS1 and possibly other viral proteins. This relates to
observations made with PB2 in mammalian cells [13,14].
The PB2 proteins may directly influence viral transcrip-
tion and replication [16]. Alternatively, the PB2 proteins
of the Yama and Vac viruses could interact differently
with viral and cellular proteins such as nucleoproteins
[24] or host-specific importin-a isoforms [11,12].
Conclusions
The inhibition of type I IFN induction by HPAIV in HD-
11 is a complex property that involves the NS1 and the
PB2 of the viral polymerase complex. This inhibition is
restricted to particular cell types. From these data one
may speculate that the capacity of the HP Yama virus as
opposed to the LP Vac virus to counteract early type I IFN
induction at the primary replication sites in vivo contri-
butes to the rapid establishment of infection and fast dis-
semination in the infected chicken host [19,25].
Methods
Cells
DF-1 chicken fibroblast cells (ATCC, LGC Standards,
Molsheim, France) were propagated in DMEM + Gluta-
MAX-I (Invitrogen, Basel, Switzerland) in the presence of
10% heat-inactivated fetal bovine serum (FBS, Biowest) at
39°C and 5% CO2. The chicken macrophage-like cell line
HD-11 (ATCC) [26] was cultivated in DMEM + Gluta-
MAX-I supplemented with 2% of chicken serum (Invitro-
gen) and 8% heat-inactivated FBS at 39°C with 5% CO2.
The quail fibroblast cell line CEC-32 carrying a luciferase
gene controlled by the chicken Mx promoter [27] was
kindly provided by Dr Peter Staeheli, University of Frei-
burg, Germany. CEC-32 cells were kept in DMEM + Glu-
taMAX-I supplemented with heat-inactivated 8% FBS
and 2% chicken serum at 39°C and 5% CO2.H u m a n
embryonic kidney (HEK) 293T cells (ATCC) were cul-
tured in DMEM + GlutaMAX-I supplemented with 10%
FBS at 37°C with 5% CO2. Madin-Darby canine kidney
(MDCK) cells were grown in minimal essential medium
(Invitrogen) supplemented with 10% fetal bovine serum
(FBS), nonessential amino acids (Invitrogen), and 1 mM
sodium pyruvate (Invitrogen) at 37°C with 5% CO2.
Chicken splenocytes were isolated by cutting spleen into
small pieces and disrupting cell aggregates through a 40
μm cell strainer (Becton Dickinson) followed by purifica-
tion of the cells using Ficoll gradient centrifugation
( 1 . 0 7 7 g / m l ,G EH e a l t h c a r e ;6 0 0×g ,2 0m i n ) .A f t e rt w o
washes with PBS (250 × g, 10 min), the cells were cul-
tured in DMEM, 10% FBS and 2% autologous chicken
serum in 96-well plates at 2.5 × 10
5 cells/well, and stimu-
lated with viruses for 24 h.
Viruses
The viruses HPAIV H5N1 A/chicken/Yamaguchi/7/04
(Yama), HPAIV H5N1 A/whooper swan/Mongolia/3/05
and LPAIV H5N1 A/duck/Hokkaido/Vac-1/04 (Vac)
were generated by reverse genetics using pHW2000-
derived plasmids with the permission of Robert G. Web-
ster (Department of Infectious Diseases, St. Jude Chil-
dren’s Research Hospital, Memphis, Tennessee, USA).
The Vac virus is composed of the NA and NS gene seg-
ments from A/duck/Mongolia/47/01 (H7N1) and the
PB2, PB1, PA, HA, NP, and M segments from A/duck/
Mongolia/54/01 (H5N2) (for references see Table 1).
The HPAIV A/turkey/Turkey/1/2005 (H5N1) isolate
was kindly provided by Dr. William Dundon, IZSV
Instituto Zooprofilattico Sperimentale delle Venezie,
Venice, Italy. For the rescue of infectious viruses, co-cul-
tures of HEK 293T and MDCK cells were transfected
with the sets of eight pHW2000-derived plasmids essen-
tially as described elsewhere [28,29]. Briefly, HEK 293T
and MDCK cells were seeded in 2 ml of Opti-MEM I +
GlutaMAX-I medium (Invitrogen), incubated overnight,
and transfected with 1 μl TransIT-293 per 1 μgp l a s m i d
mixture as described by the manufacturer (Mirus). One
day post transfection, the medium was replaced with
Opti-MEM I + GlutaMAX-I containing 1 μg/ml of irra-
diated TPCK-trypsin (Worthington). Cell culture super-
natants were harvested three days later and viruses were
propagated in embryonated chicken eggs as described
previously [29]. Alternatively, the viruses were propa-
g a t e di nM D C Kc e l l s .T ot h i se n d ,c o n f l u e n tM D C K
cells were infected at a MOI of 0.1 using Opti-MEM I
medium containing 1 ug/ml irradiated TPCK-trypsin.
Virus containing supernatants were harvested 36 to 42 h
after infection. The virus titre was determined by end-
point dilution in MDCK cells in the presence of 1 μg/ml
TPCK-trypsin, and expressed as 50% tissue culture
infectious doses (TCID50)/ml according to the Reed-
Muench formula (WHO Manual on Animal Influenza
Diagnosis and Surveillance). For particular experiments,
virus was inactivated chemically using 2-bromoethyla-
mine hydrobromide as previously described [29].
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The alanine to valine substitution at the amino acid posi-
tion 144 of the Yama NS1 protein was introduced with
PCR-based site-directed mutagenesis using the 5’ phos-
phorylated oligonucleotides Y-NS1mutAV-R (5’-TCCTTC
TTCTGTGAAAACTCTAAG-3’) and Y-NS1mutAV-F (5’-
GCAATCGTGGGAGAAATCTCAC-3’). The PCR was
performed according to standard protocols using the
pHW2000-derived plasmid carrying the Yama NS segment
as template and the Accuprime Pfx polymerase (Invitro-
gen). The resulting DNA fragment was religated, and sub-
sequent plasmid DNA was purified from transformed
E. coli. The nucleotide sequence of the mutated NS1 seg-
ment was verified by automated DNA sequencing using
the ABI 3130 Genetic Analyzer (Life Technologies).
AIV infection of cells
HD-11 macrophages and DF-1 fibroblasts were seeded in
24-well cell culture plates at a density of 5 × 10
5 cells per
well. The next day, the cells were infected at a MOI of 0.05
TCID50/cell with selected viruses produced on MDCK cells.
Chicken splenocytes were seeded in 96-well cell culture
plates at a density of 2.5 × 10
5 cells per well in 0.1 ml of
DMEM + GlutaMAX-I supplemented with 16% FBS and
4% chicken serum. The splenocytes were immediately
infected with 5-fold serial dilutions of virus in 0.1 ml Opti-
MEM I + GlutaMAX-I. At different times after infection,
the virus titre in the supernatant was determined in MDCK
cells as described above, and type I IFN bioactivity was
quantified with the bioassay described below. In order to
monitor the survival of the HD-11 cells after infection, the
cells were fixed and stained with a crystal violet solution
containing 1% formaldehyde, 0.5% (w/v) crystal violet and
30% ethanol. The fixed and stained cells were washed exten-
sively with tap water and treated with lysis solution com-
posed of 0.6% SDS and 40 mM HCl in Isopropanol. The
optical density of the crystal violet was measured at 595 nm.
SDS-PAGE and Western blot analysis
Cells were lysed in a hypotonic buffer containing 20 mM
morpholinepropanesulfonic acid, 10 mM NaCl, 1.5 mM
MgCl2, 1% Triton X-100 (pH 6.5), and protease inhibitor
cocktail (Sigma). Proteins were separated by SDS-PAGE
under reducing conditions and analysed by Western blot-
ting (41) using anti-V5 (Invitrogen), anti-HaloTag (Pro-
mega), or anti- -actin (C4) antibodies (Santa Cruz) and
IRDye-labeled secondary antibodies (Li-Cor Biosciences).
The signals were acquired and quantified using the Odys-
sey infrared imaging system (Li-Cor Biosciences).
Chicken type I IFN bioassay in CEC-32 cells and transient
chicken IFN-b promoter assay in DF-1 cells
The type I IFN bioactivity in the supernatants of stimu-
lated cells was measured with an Mx promoter-driven
luciferase reporter bioassay described elsewhere [27] and
adapted for the 96-well plate format. Briefly, CEC-32
cells were seeded in 96-well plates at a density of 2 × 10
4
cells per well. The next day, dilutions of recombinant
chicken IFN-a (kindly provided by Dr. Peter Staeheli,
Freiburg, Germany) and virus-inactivated samples were
added to the CEC-32 cells. The samples containing infec-
tious virus were inactivated at 65°C for 30 minutes prior
to the addition to the CEC-32 cells. Chicken IFN-a was
resistant to this treatment. After 6 h of incubation at 39°
Cw i t h5 %C O 2, the CEC-32 cells were lysed and lucifer-
a s ea c t i v i t yw a sd e t e r m i n ed using the Centro LB 960
luminometer (Berthold technologies). The data were
expressed as type I IFN units per ml of sample. For the
transient chicken IFN-b promoter reporter assay, DF-1
cells seeded at a density of 2-4 × 10
4 cells/well in a 96-
well plate were co-transfected with 25-50 ng/well of the
reporter plasmid pGL3-P-chIFN-b-luc expressing firefly
luciferase under the control of the chicken IFN-b promo-
ter [22] and with 0.1 ng/well of the plasmid phRL-SV40
(Promega) for constitutive expression of Renilla lucifer-
ase, using Fugene HD (Roche). Where indicated, plas-
mids for cytomegalovirus promoter driven expression of
chCARDIF and N-chMDA5 were used to induce the
IFN-b promoter-mediated luciferase expression [22]. The
cells were lysed at different times after stimulation using
20 μl of 1× passive lysis buffer (Promega). The samples
were assayed for firefly and Renilla luciferase activity
using the Dual-Luciferase Reporter Assay System (Pro-
mega) and the Centro LB 960 luminometer (Berthold
Technologies). The firefly luciferase activity was normal-
ized with the corresponding Renilla luciferase activity.
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